Ayleen Daianna Rivera Tenorio

Dr. Ayleen Daianna Rivera Tenorio


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2022 in Colombia Medica
Verified
Journal Article
Open access
PDF file
ATAyleen Daianna Rivera Tenorio
Ayleen Daianna Rivera Tenorio
HHHector Hernández-Díaz
Hector Hernández-Díaz
PTPablo Andrés Triana
Pablo Andrés Triana
JPJuliana Gutiérrez- Posso
Juliana Gutiérrez- Posso
AOAna María Osorio-Gómez
Ana María Osorio-Gómez
JPJose Darío Portillo-Miño
Jose Darío Portillo-Miño
Case description:A 22-year-old female patient received the first dose of Pfizer-BioNTech vaccine (RNAm) against COVID-19; 6 days later, she presented abdominal pain located in the right hypochondrium and epigastrium, associated with emetic episodes. Consultation 21 days later due to the same symptoms; three days after the seconddose of the vaccine was administered. Clinical findings:Pain on palpation in the right hypochondrium. Laboratories reported hepatocellular lesions and cholestasis, with negative amylase, hepatotropic virus and autoimmune hepatitis tests. Liver and biliary tract ultrasound and cholangioresonance were normal. Treatment and Results:Hyoscine and intravenous fluids as support therapy. She presented improvement in abdominal pain and a progressive decrease of transaminases and bilirubin levels until normalization and was discharged on the fifth day of hospitalization. A drug-associated hepatotoxicity (DILI) diagnosis was considered probable, in this case, secondary to vaccination against COVID-19. Clinical Relevance:The current SARS-CoV-2 pandemic has spurred the development of new vaccines, the safety of which remains a concern. There is a likely causal relationship between vaccination and liver involvement in this clinical case rather than simply a sporadic occurrence.

15 September 2021 in Revista Colombiana de Gastroenterología
Verified
Journal Article
Open access
PDF file
ATAyleen Daianna Rivera Tenorio
Ayleen Daianna Rivera Tenorio
MPMarcela Patiño
Marcela Patiño
JCJosé Mauricio Ocampo Chaparro
José Mauricio Ocampo Chaparro
JSJuliana Suarez
Juliana Suarez
GLGildardo López
Gildardo López
WSWilliam Salazar
William Salazar
La strongiloidiasis es una infección causada por el parásito strongyloides stercolaris (SS), se asocia con una alta mortalidad en pacientes inmunosuprimidos debido a una diseminación larvaria y síndrome de hiperinfección. El compromiso de la mucosa gástrica es raro, pero cuando se presenta se caracteriza por sangrado digestivo y emesis persistente. Se presenta el caso de un paciente de 27 años con síntomas gastrointestinales, antecedente de infección por HTLV-1 y colitis ulcerativa, quien desarrolló síndrome de hiperinfección por SS. Se describe la presentación clínica, diagnóstico, tratamiento y complicaciones derivadas del cuadro infeccioso.